logo

For the Inventor, By the Inventor

Oelsted, Denmark

Kenneth Jensen

This inventor holds 12 USPTO granted patents and 18 published patent applications and 6 EPO patents. Top assignees: Novozymes A/s, Novozymes, Inc.. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenneth Jensen. Retrieved from https://idiyas.com/inventor/kenneth-jensen-ugp509ex

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 

% Patents Active = 75.0

 

Average Co-Inventor Count = 9.7

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Bagsvaerd, DK (2019 - 2020)
  • Oelsted, DK (2016 - 2024)
  • Delsted, DK (2024)

Company Filing History:

goldMedal12 out of 1,426 
 
Novozymes A/s
 patents
silverMedal1 out of 384 
 
Novozymes, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2016-2026

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 12662692 - GH30 in Wet Milling (2026-06-23),
2. 12590273 - STABILIZED GLYCOSIDE HYDROLASE VARIANTS (2026-03-31),
3. 11993762 - Polypeptides having alpha-mannan degrading activity and polynucleotides encoding same (2024-05-28),
4. 11946079 - Method for producing a protein hydrolysate using an endopeptidase and a carboxypeptidase (2024-04-02),
5. 11746366 - GH5 and GH30 in wet milling (2023-09-05),
6. 11254919 - Polynucleotide encoding polypeptide having carboxypeptidase activity (2022-02-22),
7. 10858637 - Polypeptides with lipase activity and polynucleotides encoding same (2020-12-08),
8. 10724054 - Use of serine proteases for improving ethanol yield (2020-07-28),
9. 10584325 - Cellobiohydrolase variants and polynucleotides encoding same (2020-03-10),
10. 10221406 - Cellobiohydrolase variants and polynucleotides encoding same (2019-03-05),
11. 9988616 - Polypeptides having xanthan degrading activity and polynucleotides encoding same (2018-06-05),
12. 9458441 - Polypeptides having xanthan degrading activity and polynucleotides encoding same (2016-10-04),

Title: Biography of Inventor Kenneth Jensen

Introduction: Kenneth Jensen is a notable inventor based in Oelsted, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptides and methods for protein hydrolysis. With a total of 10 patents to his name, Jensen's work has had a considerable impact on various applications in the industry.

Latest Patents: Among his latest patents is a composition involving polypeptides that exhibit alpha-mannan degrading activity. This invention encompasses the polypeptides themselves, as well as the polynucleotides that encode them. Additionally, he has developed a method for producing a protein hydrolysate using specific enzymes, including an endopeptidase and a carboxypeptidase. This method highlights the innovative use of these enzymes for hydrolyzing protein substrates.

Career Highlights: Kenneth Jensen has worked with prominent companies in the biotechnology sector, including Novozymes A/S and Novozymes, Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development.

Collaborations: Throughout his career, Jensen has collaborated with esteemed colleagues such as Lorena G. Palmen and Tine Hoff. These partnerships have fostered a collaborative environment that has led to the advancement of innovative solutions in biotechnology.

Conclusion: Kenneth Jensen's contributions to the field of

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…